Black Diamond Therapeutics (BDTX) Total Current Liabilities: 2018-2020
Historic Total Current Liabilities for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $14.2 million.
- Black Diamond Therapeutics' Total Current Liabilities rose 132.44% to $26.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $26.4 million, marking a year-over-year increase of 132.44%. This contributed to the annual value of $14.2 million for FY2020, which is 192.37% up from last year.
- As of FY2020, Black Diamond Therapeutics' Total Current Liabilities stood at $14.2 million, which was up 192.37% from $4.9 million recorded in FY2019.
- Black Diamond Therapeutics' Total Current Liabilities' 5-year high stood at $14.2 million during FY2020, with a 5-year trough of $2.6 million in FY2018.
- Over the past 3 years, Black Diamond Therapeutics' median Total Current Liabilities value was $4.9 million (recorded in 2019), while the average stood at $7.2 million.
- Data for Black Diamond Therapeutics' Total Current Liabilities shows a peak YoY surged of 192.37% (in 2020) over the last 5 years.
- Black Diamond Therapeutics' Total Current Liabilities (Yearly) stood at $2.6 million in 2018, then skyrocketed by 88.85% to $4.9 million in 2019, then surged by 192.37% to $14.2 million in 2020.